The Prostate

Cover image for Vol. 74 Issue 16

December 2014

Volume 74, Issue 16

Pages 1579–1696

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. 8q24 risk alleles and prostate cancer in African-Barbadian men (pages 1579–1588)

      Cheryl D. Cropp, Christiane M. Robbins, Xin Sheng, Anselm J.M. Hennis, John D. Carpten, Lyndon Waterman, Ronald Worrell, Tae-Hwi Schwantes-An, Jeffrey M. Trent, Christopher A. Haiman, M. Cristina Leske, Suh-Yuh Wu, Joan E. Bailey-Wilson and Barbara Nemesure

      Article first published online: 22 SEP 2014 | DOI: 10.1002/pros.22871

    2. Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions (pages 1604–1612)

      Atsushi Maeno, Naoki Terada, Masayuki Uegaki, Takayuki Goto, Yoshiyuki Okada, Takashi Kobayashi, Tomomi Kamba, Osamu Ogawa and Takahiro Inoue

      Article first published online: 29 AUG 2014 | DOI: 10.1002/pros.22877

    3. miR-146a functions as a tumor suppressor in prostate cancer by targeting Rac1 (pages 1613–1621)

      Qian Sun, Xian Zhao, Xin Liu, Yanli Wang, Jian Huang, Bing Jiang, Qin Chen and Jianxiu Yu

      Article first published online: 11 SEP 2014 | DOI: 10.1002/pros.22878

    4. Co-targeting androgen receptor and DNA for imaging and molecular radiotherapy of prostate cancer: In vitro studies (pages 1634–1646)

      Guang Han, Zbigniew P. Kortylewicz, Thomas Enke and Janina Baranowska-Kortylewicz

      Article first published online: 11 SEP 2014 | DOI: 10.1002/pros.22880

    5. Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers (pages 1647–1654)

      Achim Fleischmann, Outi R. Saramäki, Inti Zlobec, Diana Rotzer, Vera Genitsch, Roland Seiler, Tapio Visakorpi and George N. Thalmann

      Article first published online: 22 SEP 2014 | DOI: 10.1002/pros.22882

    6. Investigation of miR-21, miR-141, and miR-221 expression levels in prostate adenocarcinoma for associated risk of recurrence after radical prostatectomy (pages 1655–1662)

      Qizhi Zheng, Sarah B. Peskoe, Judit Ribas, Fatema Rafiqi, Tarana Kudrolli, Alan K. Meeker, Angelo M. De Marzo, Elizabeth A. Platz and Shawn E. Lupold

      Article first published online: 22 SEP 2014 | DOI: 10.1002/pros.22883

    7. Dietary methionine restriction inhibits prostatic intraepithelial neoplasia in TRAMP mice (pages 1663–1673)

      Raghu Sinha, Timothy K. Cooper, Connie J. Rogers, Indu Sinha, William J. Turbitt, Ana Calcagnotto, Carmen E. Perrone and John P. Richie Jr.

      Article first published online: 22 SEP 2014 | DOI: 10.1002/pros.22884

    8. Comparative analysis of monoclonal antibodies against prostate-specific membrane antigen (PSMA) (pages 1674–1690)

      J. Tykvart, V. Navrátil, F. Sedlák, E. Corey, M. Colombatti, G. Fracasso, F. Koukolík, C. Bařinka, P. Šácha and J. Konvalinka

      Article first published online: 27 SEP 2014 | DOI: 10.1002/pros.22887

    9. Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide (pages 1691–1696)

      Vincenza Conteduca, Salvatore Luca Burgio, Cecilia Menna, Elisa Carretta, Lorena Rossi, Emanuela Bianchi, Carla Masini, Dino Amadori and Ugo De Giorgi

      Article first published online: 27 SEP 2014 | DOI: 10.1002/pros.22890

SEARCH

SEARCH BY CITATION